Biom’Up, a French company that specialises in the manufacture of re-absorbable medical devices based on collagen technology, has raised €6.8m in financing from existing shareholders and acquired three new investors.
The company will use the new funding to help speed up its commercial development and to finance clinical studies into two new medical implant ranges.
